Cancer Gene Therapy - Table of Contents alert Volume 23 Issue 10

If you are unable to see the message below, click here to view.

Advertisement Nature Outlook: Precision Medicine Health care that is tailored on the basis of an individual's genes, lifestyle or environment, is not a modern concept. But advances in genetics and the growing availability of health data for researchers and physicians promise to make this new era of medicine more personalized than ever before. Access the Outlook free online Sponsored by:  Illumina, Inc.   TABLE OF CONTENTS Volume 23, Issue 10 (October 2016) In this issue Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Have you tried listening to the Genepod, the podcast from Genetics in Medicine? Hear direct from the experts, wherever you are and on whatever device. Past topics have included: Investigating the lower risk of solid tumors in Down Syndrome New and Old Quandaries in Newborn Screening Time and effort to practice medical genetics: an expanding challenge Listen to the Genepod and expand your genetics knowledge for free Original Articles Top Circulating microRNA-192 as a diagnostic biomarker in human chronic lymphocytic leukemia S Fathullahzadeh, H Mirzaei, M A Honardoost, A Sahebkar and M Salehi Cancer Gene Ther 2016 23: 327-332; advance online publication, September 23, 2016; 10.1038/cgt.2016.34 Abstract | Full Text Small activating RNA upregulates NIS expression: promising potential for hepatocellular carcinoma endoradiotherapy W Xia, D Li, G Wang, J Ni, J Zhuang, M Ha, J Wang and Y Ye Cancer Gene Ther 2016 23: 333-340; advance online publication, September 9, 2016; 10.1038/cgt.2016.36 Abstract | Full Text Gene therapy using plasmid DNA-encoded anti-HER2 antibody for cancers that overexpress HER2 OPEN H Kim, S N Danishmalik, H Hwang, J-I Sin, J Oh, Y Cho, H Lee, M Jeong, S-H Kim and H J Hong Cancer Gene Ther 2016 23: 341-347; advance online publication, September 16, 2016; 10.1038/cgt.2016.37 Abstract | Full Text The PARP inhibitor ABT-888 potentiates dacarbazine-induced cell death in carcinoids Y Somnay, S Lubner, H Gill, J B Matsumura and H Chen Cancer Gene Ther 2016 23: 348-354; advance online publication, September 16, 2016; 10.1038/cgt.2016.39 Abstract | Full Text Expression of the fusogenic p14 FAST protein from a replication-defective adenovirus vector does not provide a therapeutic benefit in an immunocompetent mouse model of cancer OPEN C M Wong, L A Nash, J Del Papa, K L Poulin, T Falls, J C Bell and R J Parks Cancer Gene Ther 2016 23: 355-364; advance online publication, October 14, 2016; 10.1038/cgt.2016.41 Abstract | Full Text Enhanced detection sensitivity of prostate-specific antigen via PSA-conjugated gold nanoparticles based on localized surface plasmon resonance: GNP-coated anti-PSA/LSPR as a novel approach for the identification of prostate anomalies M H Jazayeri, H Amani, A A Pourfatollah, A Avan, G A Ferns and H Pazoki-Toroudi Cancer Gene Ther 2016 23: 365-369; advance online publication, October 14, 2016; 10.1038/cgt.2016.42 Abstract | Full Text Advertisement A new open access journal dedicated to publishing the most important scientific advances in all aspects of genomics and its application in the practice of medicine. Part of the Nature Partner Journals series, the journal is published in partnership with the Center of Excellence in Genomic Medicine Research.  Open for submissions Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Cancer Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.